Anifrolumab, a potential treatment for ADA2 deficiency.

Vincenti L, Sormani J, Belot A, Richard M, Roubertou Y, Grienay-Poletto N, Foray AP, Nombel A, Durieu I, Reynaud Q

DOI: 10.1136/rmdopen-2025-006569
Published: 2026 Jul 6
Container: RMD open
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/rmdopen-2025-006569,
  title = {Anifrolumab, a potential treatment for ADA2 deficiency.},
  author = {Vincenti L and Sormani J and Belot A and Richard M and Roubertou Y and Grienay-Poletto N and Foray AP and Nombel A and Durieu I and Reynaud Q},
  year = {2026},
  journal = {RMD open},
  doi = {10.1136/rmdopen-2025-006569},
  url = {https://doi.org/10.1136/rmdopen-2025-006569}
}

RIS

TY  - JOUR
TI  - Anifrolumab, a potential treatment for ADA2 deficiency.
AU  - Vincenti L
AU  - Sormani J
AU  - Belot A
AU  - Richard M
AU  - Roubertou Y
AU  - Grienay-Poletto N
AU  - Foray AP
AU  - Nombel A
AU  - Durieu I
AU  - Reynaud Q
PY  - 2026
JO  - RMD open
DO  - 10.1136/rmdopen-2025-006569
UR  - https://doi.org/10.1136/rmdopen-2025-006569
ER  -

APA

L, V., J, S., A, B., M, R., Y, R., N, G., AP, F., A, N., I, D., & Q, R. (2026). Anifrolumab, a potential treatment for ADA2 deficiency.. RMD open. https://doi.org/10.1136/rmdopen-2025-006569

Source records

pubmed · retrieved 2026-09-26T12:52:58.732Z